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Background:  The aim of the present study was to determine the population-based prevalence of diabetes mellitus (DM) and 
prediabetes in a rural district of Daegu City, Korea.
Methods:  Between August and November 2003, a community-based health survey of adults aged 20 years and older was per-
formed in the rural district of Dalseong-gun in Daegu City. A total of 1,806 of all eligible individuals agreed to participate. Fast-
ing plasma glucose was measured in all participants. Two hour oral glucose tolerance was measured in the 1,773 participants for 
whom there was neither an established diagnosis of DM nor evidence of DM according to fasting glucose levels. The prevalence 
of DM and prediabetes was determined according to the 2003 criteria of the American Diabetes Association. Subjects with pre-
diabetes were classified into one of three categories of glucose intolerance: isolated impaired fasting glucose (IFG); isolated  im-
paired glucose tolerance (IGT); or combined IFG and IGT.
Results:  The prevalence of DM was 12.2%. The highest prevalence rates were observed in subjects in their seventies. A total of 
34.7% of all subjects who were assigned a diagnosis of DM in the present study had not been diagnosed previously. The preva-
lence of prediabetes was 22.7%. The highest prevalence rates were observed in subjects in their fifties. 
Conclusion:  The present study identified prevalence rates of 12.2% for DM (age-standardized prevalence rate [ASR], 6.8%), and 
22.7% for prediabetes (ASR 18.5%). These results emphasize the need for community health promotion strategies to prevent or 
delay the onset of DM in individuals with prediabetes.
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INTRODUCTION
In South Korea, economic development and altered eating 
patterns have been accompanied by increased rates of over-
weight, obesity, and diabetes mellitus (DM) [1,2]. The preva-
lence of diabetes mellitus (DM) in South Korea has increased 
over the past three decades, from 0.91% in Jeollabuk-do Prov-
ince in 1971 to 7.2% in Yonchon in 1993, and from 7.1% in 
Jungup in 1997 to 13.7% in Namwon in 1999, and most dra-
matically, to 20.5% and 22.1% in southwestern Seoul in 1999 
and 2002, respectively [1-8]. 
  A study in the Korean city of Daegu in 2001 demonstrated 
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that endocrine disease was the fifth leading cause of death, and 
that DM in particular had been associated with a two-fold in-
crease in mortality over the preceding decade [9]. In 2003, a 
hypertension-DM management center was established in 
Daegu to facilitate the prevention and early treatment of DM 
and hypertension. This initiative was the result of collabora-
tion between public and private health care providers. An epi-
demiological research team was created to investigate the 
prevalence of hypertension, DM, and metabolic syndrome in 
local residents, and to recruit a cohort to investigate disease 
incidence over a 5-year period, as well as determination of risk 
and prognostic factors. 
  The aim of the present study was to determine the preva-
lence of DM and prediabetes in the population of the rural 
district of Dalseong-gun in Daegu, a population which is less 
mobile than those in other areas of Daegu City.
METHODS
Study subjects
Between August and November 2003, a community-based 
health survey was performed in Dalseong-gun to determine 
the prevalence of DM and prediabetes in adults aged 20 years 
or older. Dalseong-gun is a rural district of Daegu, Korea. Ac-
cording to the 2000 census, approximately 101,104 of its resi-
dents are above the age of 20 years. The study population was 
selected using a multi-stage cluster sampling method without 
use of a weight factor. The catchment areas of nine primary 
health care centers were selected as collection districts. Two or 
three villages from each collection district were then selected 
at random. Thus, a total of 26 villages were sampled and 1,806 
individuals were recruited.
  A total of 1,773 subjects (681 men and 1,092 women) under-
went a full evaluation of glucose tolerance status. Since meta-
bolic risk factor data were available for only 1,755 of the 1,773 
subjects, only these were included in the analysis of metabolic 
risk factors. The study was approved by the Institutional Re-
view Board of Kyungpook National University Hospital, and 
all subjects provided written informed consent.
Methods
All subjects underwent a standardized series of physical ex-
aminations that were performed by trained personnel. Systolic 
blood pressure (SBP) and diastolic blood pressure (DBP) were 
measured in the sitting position after a 10-minute period of 
rest. The average of two blood pressure readings was used in 
the analysis. Weight (measured without shoes and in light out-
door clothing) and height were measured, and body mass in-
dex (BMI, kg/m
2) was calculated by dividing weight (kg) by 
height squared (m
2). Waist circumference was measured mid-
way between the lower rib margin and the iliac crest at the end 
of expiration. 
  All blood samples were taken in the morning following an 
overnight fast of at least eight hours. Venous blood was drawn 
with minimal stasis from the antecubital vein. In all subjects, 
fasting capillary whole blood glucose was measured with an 
Accu Check
® glucometer (Roche Diagnostics, Penzberg, Ger-
many), and fasting plasma glucose was measured with a Beck-
man Glucose Analyzer
® (Beckman Instruments, Irvine, CA, 
USA). All eligible participants were then subjected to an oral 
glucose tolerance test (OGTT). A 75-g glucose solution was 
administered orally, and plasma glucose was measured after 
an interval of two hours. Participants with known DM or a 
fasting capillary whole blood glucose level of ≥200 mg/dL were 
excluded from the analysis of oral glucose tolerance. In these 
participants, DM was confirmed by re-checking fasting plas-
ma glucose levels. Serum total cholesterol (TC), triglycerides 
(TG), and high density lipoprotein cholesterol (HDL-C) were 
measured using enzymatic methods (Dimension AR; Dade 
Behring Inc., Deerfield, IL, USA).
  DM and prediabetes were diagnosed according to the 2003 
criteria of the American Diabetes Association (ADA) [10]. A 
subject was considered to have known DM if they were receiv-
ing pharmacological treatment for DM at the time of inclusion 
in the study, irrespective of their measured glucose levels. Sub-
jects with a fasting plasma glucose level of ≥126 mg/dL or a 
2-hour post-load plasma glucose level of ≥200 mg/dL were 
assigned a diagnosis of DM. Subjects with prediabetes were 
classified into one of three categories: isolated impaired fasting 
glucose (I-IFG), isolated impaired glucose tolerance (I-IGT), 
or combined IFG and IGT (C-IFG/IGT) [10,11]. I-IFG was 
defined by a fasting plasma glucose level of between 100 and 
125 mg/dL, and a 2-hour post-load plasma glucose level of 
<140 mg/dL. I-IGT was defined by a fasting plasma glucose 
level of <100 mg/dL, and a 2-hour post-load plasma glucose 
level of between 140 and 199 mg/dL. C-IFG/IGT was defined 
by a fasting plasma glucose level of between 100 and 125 mg/
dL, and a 2-hour post-load plasma glucose level of between 
140 and 199 mg/dL.257
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Statistical analysis
The age-standardized prevalence rate (ASR) of DM and predi-
abetes and the 95% confidence interval (CI) were calculated 
using the 2005 Korean population (aged 20 to 99 years) as the 
standard population. The age groups 20 to 39, 40 to 49, 50 to 
59, 60 to 69, and ≥70 years were considered separately. The 
chi-square test was used to analyze differences in the preva-
lence of DM and prediabetes between the sexes and different 
age groups. For both DM and prediabetes, prevalence was an-
alyzed without use of a weight factor. Logistic regression mod-
els were used to assess the relationship between metabolic risk 
factors and DM and prediabetes. All data were analyzed using 
the SPSS statistical package version 15.0 (SPSS Inc., Chicago, 
IL, USA).
RESULTS 
Demographic characteristics
Data from 1,773 subjects were analyzed (681 men, 38.4%; 1,092 
women, 61.6%). The mean age was 58.7 years (59.1 in men, 
58.5 in women) (Table 1).
Prevalence of diabetes mellitus
The prevalence of DM was 12.2% (ASR 6.8%). No statistically 
significant difference in the prevalence of DM was observed 
between men and women (13.1% [ASR 6.6%] in men; 11.6% 
[ASR 7.0%] in women). A total of 34.7% of all subjects who 
were assigned a diagnosis of DM had not been previously di-
agnosed (39.3% men, 31.5% women). The prevalence of DM 
increased with age, and peaked in the age-group ≥70 years (P 
for trend<0.01). The highest prevalence rates were detected in 
the age group 60 to 69 years for men (P for trend<0.01) and in 
the age group ≥70 years for women (P for trend<0.01) (Table 2).
Prevalence of prediabetes
The prevalence of prediabetes was 22.7% (ASR 18.5%) overall, 
26.1% (ASR 27.1%) in men and 20.5% (ASR 13.9%) in wom-
en. The prevalence of I-IFG was 15.3% (ASR 13.2%), 19.4% 
(ASR 20.8%) in men and 12.8% (ASR 9.0%) in women. The 
prevalence of I-IGT was 3.7% (ASR 2.6%), 3.8% (ASR 3.7%) in 
men and 3.6% (ASR 2.0%) in women. The prevalence of C-
IFG/IGT was 3.7% (ASR 2.7%), 2.9% (ASR 2.5%) in men and 
4.1% (ASR 2.9%) in women. The prevalence of I-IFG was sig-
Table 1. Age and sex of study subjects
Age, yr Men Women Total
20-39 43 (6.3) 76 (7.0) 119 (6.7)
40-49 110 (16.2) 191 (17.5) 301 (17.0)
50- 9 169 (24.8) 243 (22.3) 412 (23.2)
60-69 209 (30.7) 390 (35.7) 599 (33.8)
≥70 150 (22.0) 192 (17.6) 342 (19.3)
Total 681 (38.4) 1,092 (61.6) 1,773 (100.0)
Data are presented as number (%).
Table 2. Prevalence of diabetes mellitus according to sex and age
Age, yr
Previously diagnosed diabetes, % Newly diagnosed diabetes, % Total diabetes mellitus, %
Men Women Total Men Women Total Men Women Total
20-39 0.0 1.3 0.8 2.3 1.3 1.7 2.3 2.6 2.5
40-49 1.8 2.6 2.3 2.7 3.1 3.0 4.6 5.8 5.3
50-59 6.5 7.4 7.0 5.3 2.1 3.4 11.8 9.5 10.4
60-69 12.0 10.8 11.2 6.7 3.9 4.8 18.7 14.6 16.0
≥70 10.7 10.9 10.8 5.3 6.8 6.1 16.0 17.7 17.0
Total (95% CI) 7.9 
(5.9-9.9)
8.0 
(6.4-9.6)
8.0 
(6.7-9.3)
5.1 
(3.5-6.7)
3.7 
(2.6-4.8)
4.2 
(3.3-5.1)
13.1 
(10.6-15.6)
11.6 
(9.7-13.5)
12.2 
(9.7-13.5)
Age-adjusted
 a (95% CI) 4.4 
(3.2-5.6)
3.9 
(3.0-4.8)
3.2 
(1.8-4.5)
3.4 
(2.1-4.8)
2.6 
(1.7-3.6)
2.9 
(2.1-3.7)
6.6 
(4.8-8.5)
7.0 
(5.5-8.6)
6.8 
(5.6-8.0)
P value
 b 0.98 0.13 0.37
P for trend
 c < 0.01 < 0.01 < 0.01 0.19 0.02 < 0.01 < 0.01 < 0.01 < 0.01
CI, confidence interval.
aAge-adjusted prevalence (%), 
bP value for comparison between men and women, 
cP value for trend across increasing age.258
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nificantly higher than that of I-IGT or C-IFG/IGT (P<0.01) 
(Table 3). 
  The prevalence of prediabetes increased with age and peaked 
at 25.5% in the 50 to 59 year age group (P for trend<0.01). In 
men, the prevalence of prediabetes peaked at 31.8% in the age 
group 40 to 49 years. In women, the prevalence of prediabetes 
peaked at 24.3% in the age group 50 to 59 years. The preva-
lence of I-IFG did not increase with age and peaked at 19.7% 
in the age group 50 to 59 years. In men, the prevalence of I-
IFG peaked at 27.3% in the age group 40 to 49 years. In wom-
en, the prevalence of I-IFG peaked at 17.7% in the age group 
50 to 59 years. The prevalence of I-IGT increased with age (P 
for trend=0.01), and peaked in the age group ≥70 years at 5.3% 
for men and 5.2% for women. When the sexes were consid-
Table 4. Associated metabolic risk factors according to diagnostic criteria (n=1,755)
Variable NGT 
(n=1,146)
Prediabetes (n=397)
Diabetes 
(n=212) P for trend
 a I-IFG
(n=271)
I-IGT
(n=63)
C-IFG/IGT 
(n=63)
Total
(n=397)
BMI, kg/m
2 b 23.3±3.1 24.0±3.0
 c  24.4±3.7
 d 24.8±3.8
 e 24.2±3.2
 f 24.6±3.1
 g <0.01
Waist, cm
 b 81.2±8.9  84.3±8.2
 c  85.6±8.3
 d 85.7±8.4
 e 84.7±8.2
 f 87.5±8.0
 g <0.01
SBP, mm Hg
 b 129.0±17.9 133.2±18.1
 c 140.8±19.0
 d 140.1±20.5
 e 135.5±18.9
 f 139.2±20.8
 g <0.01
DBP, mm Hg
 b 81.3±10.6 83.5±10.7
 c  87.1±10.2
 d 87.2±10.6
 e 84.7±10.7
 f 84.4±10.1
 g <0.01
TG, mg/dL
 b 143.0±107.5 196.2±190.6
 c  180.9±92.6 171.2±99.3 189.9±166.6
 f 205.1±147.4
 g <0.01
TC, mg/dL
 b 193.9±35.9 203.0±34.7
 c 202.0±49.2 207.5±42.9
 e 203.6±38.6
 f 202.7±40.3
 g <0.01
HDL-C, mg/dL
 b 52.2±12.8 51.9±15.3 52.8±30.1 53.0±12.3 52.2±18.0 47.5±13.2
 g <0.01
NGT, normal glucose tolerance; I-IFG, isolated impaired fasting glucose; I-IGT, isolated impaired glucose tolerance; C-IFG/IGT, combined 
impaired fasting glucose and impaired glucose tolerance; BMI, body mass index; Waist, waist circumference; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; TG, triglyceride; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol.
a“P for trend” was used to compare normal, prediabetes, and diabetes groups, 
bExpressed as mean±SD, 
cSignificant difference of normal/isolat-
ed impaired fasting glucose (P<0.05), 
dSignificant difference of normal/isolated impaired glucose tolerance (P<0.05), 
eSignificant difference of 
normal/combined impaired fasting glucose and impaired glucose tolerance (P<0.05), 
fSignificant difference of normal/prediabetes (P<0.05), 
gSignificant difference of normal/diabetes (P<0.05). 
Table 3. Prevalence of prediabetes according to sex and age
Age, yr
I-IFG, % I-IGT, % C-IFG/IGT, % Total prediabetes,% 
Men Women Total Men Women Total Men Women Total Men Women Total
20-39 18.6 5.3 10.1 4.7 0.0 1.7 2.3 1.3 1.7 25.6 6.6 13.5
40-49 27.3 6.8 14.3 1.8 2.6 2.3 2.7 3.7 3.3 31.8 13.1 19.9
50-59 22.5 17.7 19.7 2.4 3.7 3.2 2.4 2.9 2.7 27.2 24.3 25.5
60-69 19.1 15.1 16.5 4.8 3.9 4.2 1.4 4.9 3.7 25.4 23.9 24.4
≥70 10.7 10.9 10.8 5.3 5.2 5.3 6.0 5.7 5.9 22.0 21.9 21.9
Total
(95% CI)
19.4
(16.4-22.4)
12.8
(10.8-14.8)
15.3
(13.7-17.0)
3.8
(2.4-5.2)
3.6
(2.5-4.7)
3.7
(2.8-4.6)
2.9
(1.6-4.2)
4.1
(2.9-5.3)
3.7
(2.8-4.6)
26.1
(22.8-29.4)
20.5
(18.1-22.9)
22.7
(20.8-24.6)
Age-ad-
justed
 a 
(95% CI)
20.8
(17.8-23.9)
9.0
(7.3-10.7)
13.2
(11.6-14.8)
3.7
(1.9-3.3)
2.0
(2.3-5.1)
2.6
(1.2-2.9)
2.5
(1.4-3.7)
2.9
(1.9-3.9)
2.7
(2.0-3.5)
27.1
(23.7-30.4)
13.9
(11.9-16.0)
18.5
(16.7-20.3)
P value
 b <0.01 0.79 0.20 <0.01
P for 
trend
 c
<0.01 0.05 0.65 0.17 0.04 0.01 0.19 0.06 0.03 0.14 <0.01 0.09
C-IFG/IGT, combined impaired fasting glucose and impaired glucose tolerance; I-IFG, isolated impaired fasting glucose; I-IGT, isolated im-
paired glucose tolerance, CI, confidence interval.
aAge-adjusted prevalence (%), 
bP value for comparison between men and women, 
cP value for trend across increasing age.259
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ered separately, the prevalence of I-IGT was found to increase 
with age in women (P for trend=0.04), but not in men. The 
prevalence of C-IFG/IGT also increased with age (P for trend
=0.03), and peaked in the age group ≥70 years at 6.0% for men 
and 5.7% for women (Table 3).
Associated metabolic risk factors
The analyses of metabolic risk factors revealed that BMI, waist 
circumference, SBP, and DBP were significantly higher in the 
I-IFG, I-IGT, C-IFG/IGT, and DM groups than in the normal 
glucose tolerance (NGT) group (P<0.01). TG levels were sig-
nificantly higher in the I-IFG and DM groups than in the NGT 
group (P<0.01). TC was significantly higher in the I-IFG, C-
IFG/IGT, and DM groups than in the NGT group (P<0.01). 
HDL-C was significantly lower only in the DM group com-
pared to the NGT group (P<0.01). BMI, waist circumference, 
SBP, DBP, TG, and TC were significantly increased and HDL-
C was significantly decreased in the prediabetes group com-
pared to the NGT group. Differences with the NGT group were 
more pronounced for subjects with DM than for subjects with 
prediabetes (P for trend<0.01) (Table 4). 
  Multiple logistic regression analysis adjusted for age and sex, 
and using standardized values as variables, showed that the 
following metabolic risk factors were associated with DM: waist 
circumference (odds ratio [OR], 1.817; P<0.001), SBP (OR, 
1.719; P<0.001), DBP (OR, 0.719; P=0.009), and TG (OR, 
1.302; P<0.001). Multiple logistic regression analysis adjusted 
for age and sex, and using standardized values as variables, 
showed that the following metabolic risk factors were associated 
with prediabetes: waist circumference (OR, 1.252; P=0.026), 
TG (OR, 1.310; P<0.001), TC (OR, 1.143; P=0.045), and HDL-
C (OR, 1.155; P=0.037) (Table 5).
DISCUSSION 
The prevalence of DM in Dalseong-gun, Daegu, Korea was 
12.2% (ASR 6.8%), 13.1% (ASR 6.6%) in men and 11.6% (ASR 
7.0%) in women. In both sexes, the prevalence of DM in-
creased significantly with age, and the most pronounced in-
crease was observed in the fifth decade of life. The highest 
prevalence rates were found for men in the age group 60 to 69 
years and women in the age group ≥70 years. 
  Previous studies have investigated the prevalence of DM in 
Korea using the 1997 criteria of the ADA. A prevalence of 
7.1% was reported in Jungup in 1997, and a study in Namwon 
in 1999 reported a prevalence of 13.7% [5,7]. Studies performed 
within the context of the Korean National Health and Nutri-
tional Survey reported that the prevalence of DM decreased 
between 1998 and 2001 in both sexes [12,13]. Rates of 12% in 
men and 9.7% in women were found in 1998, compared with 
9.0% and 7.2%, respectively, in 2001 [12,13]. According to an 
analysis of the Korean National Health Insurance Database on 
Diabetes in 2003, the prevalence of DM was 7.7% [14]. The 
mean age of the subjects in the present study was 58.7 years, 
which is higher than in previous studies. The ASR of DM in 
the present study was lower than that reported in previous 
studies in Korea [5,7,12-14]. The reason for this is unclear. The 
prevalence of diabetes may be lower in rural areas, where the 
population follows a more traditional lifestyle, than in urban 
areas. Furthermore, the present study included relatively young 
Table 5. Multiple logistic regression analysis of the relationship between metabolic risk factors and diabetes mellitus and predia-
betes
Metabolic risk factor
Diabetes mellitus Prediabetes
Adjusted OR
a (95% CI) P value Adjusted OR
a (95% CI) P value
BMI 0.898 (0.695–1.160) 0.409 1.106 (0.910–1.344) 0.313
Waist  1.817 (1.386–2.382) <0.001 1.252 (1.027–1.527) 0.026
SBP 1.719 (1.347–2.193) <0.001 1.176 (0.944–1.465) 0.148
DBP 0.719 (0.561–0.922) 0.009 1.034 (0.833–1.283) 0.764
TG 1.302 (1.126–1.506) <0.001 1.310 (1.139–1.506) < 0.001
TC 0.964 (0.820–1.134) 0.659 1.143 (1.003–1.302) 0.045
HDL-C 0.887 (0.742–1.062) 0.191 1.155 (1.009–1.323) 0.037
OR, odds ratio; CI, confidence interval; BMI, body mass index; Waist, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; TG, triglyceride; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol.
aOR adjusted for age and sex using standardized values as variables, P<0.05 is statistically significant.260
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subjects, because the inclusion criterion was an age of 20 years 
or above. Comparisons with previous findings may thus be 
limited, since previous studies tended to only include subjects 
who were above the age of 30 or 40 years.
  Previous studies have shown that the prevalence of DM was 
positively correlated with age, and that there was a rapid in-
crease in DM prevalence during the fifth and sixth decades of 
life [5-7,12,13]. The present results are consistent with those of 
a study in the Korean district of Jungup. This study showed 
that the prevalence of DM increased significantly throughout 
middle age in both sexes, and that the highest prevalence rates 
were in the age group 50 to 59 years for men and ≥70 years for 
women [5]. In the 1998 Korean National Health and Nutri-
tional Survey study, the prevalence of DM increased through-
out middle age, and the highest prevalence rates were observed 
in men in their fifties and in women in their sixties [12]. In the 
2005 Korean National Health and Nutritional Survey study, 
the highest prevalence rates were found for men in their fifties 
and women in their seventies [13]. 
  In the present study, 34.7% of all subjects who were assigned 
a diagnosis of DM had not been diagnosed previously. The 
percentage of newly diagnosed subjects was approximately 
50% lower than the percentages reported from comparable 
studies [5,7]. In particular, the ratio of newly to previously di-
agnosed DM in the present population was lower in the ≥50 
year age groups than in the 20 to 49 year age groups. Early de-
tection of DM appears to have increased in recent years as a 
result of screening programs. However, the present study has 
demonstrated that many subjects with DM were undiagnosed 
and untreated. 
  In the present study, the prevalence of prediabetes was 22.7% 
(ASR 18.5%). The most common category of prediabetes was 
I-IFG, which accounted for 67.4% of all subjects with predia-
betes. Together I-IGT and C-IFG/IGT accounted for 16.3% of 
all subjects with prediabetes. The prevalence of prediabetes was 
significantly higher in men than in women (P<0.01), and the 
prevalence of I-IFG was also significantly higher in men than 
in women (P<0.01). However, the prevalence of I-IGT and C-
IFG/IGT did not differ between the sexes. The highest preva-
lence of I-IFG was found in subjects in their fifties, and the rate 
decreased above the age of 60. However, the prevalence of I-
IGT and C-IFG/IGT increased significantly with age. 
  In 1999, Weyer et al. [15] were the first to classify prediabe-
tes into three categories of glucose intolerance: I-IFG, I-IGT, 
and C-IFG/IGT. The normal range of fasting plasma glucose 
was defined as <110 mg/dL, and this cutoff was applied by 
both the ADA and the World Health Organization (WHO) in 
their 1997 diagnostic criteria [16,17]. In 2001, the Internation-
al Diabetes Federation (IDF) defined prediabetes according to 
the same criteria as the WHO [11]. However, the 2003 criteria 
of the ADA defined the normal range of fasting plasma glu-
cose as <100 mg/dL [10]. Therefore, the prevalence of predia-
betes identified in the present study cannot be directly com-
pared with that reported by previous studies in Korea because 
different fasting plasma glucose cutoff values were used. A 
population study performed at a health promotion center in 
Gyeonggi-do in 2006 reported that 46.4% of subjects had pre-
diabetes. Of these, 20.7% had I-IFG, 7.7% had I-IGT, and 18.0% 
had C-IFG/IGT [18]. It is impossible to directly compare the 
results of this study with the present findings, since a fasting 
plasma glucose cut off value of <110 mg/dL was used [18]. Yet, 
the prevalence of prediabetes in the present study was lower, 
despite the use of a lower fasting plasma glucose cutoff value 
of <100 mg/dL. Recently, a pooled analysis of four large-scale 
Korean community-based studies was performed. This includ-
ed data from the 1993 Yonchon study, the 1997 Mokdong study, 
the 1997 Jungup study, and the 2000 Ansan study [19]. Using 
the optimal cutoff point for fasting plasma glucose of 100 mg/
dL, the prevalence of prediabetes was found to be 29.8% (I-
IFG 17.0%, I-IGT 6.7%, and C-IFG/IGT 6.1%) [19]. Thus, the 
study reported a higher prevalence of prediabetes than in the 
present study. However, it disclosed lower rates of I-IFG com-
pared to I-IGT and C-IFG/IGT than in the present study [19].
  Several studies have investigated the pathophysiology of 
IFG and IGT [11,15,20-26]. In the majority of the populations 
studied, IGT was more prevalent than IFG, and differences in 
phenotype and gender distribution were observed between 
the two categories [11]. The 5-year Inter99 study of a Danish 
population suggested that I-IFG appears to be caused by im-
paired basal insulin secretion and first-phase insulin release, 
and a subsequent decline in hepatic insulin sensitivity [22]. In 
contrast, the authors suggested that the I-IGT may be caused 
by low whole body insulin sensitivity and a progressive decline 
in β-cell function, which indicates a loss of β-cell compensa-
tion [22]. This implies there are differences in pathogenesis 
between the various forms of prediabetes, and thus in the risk 
of developing DM. The findings of the present study suggest 
that Korean individuals with prediabetes are genetically more 
susceptible to inherent insulin secretory dysfunction and he-
patic insulin resistance than to an inadequate compensatory 261
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insulin secretory response and peripheral insulin resistance. 
Further studies are warranted to determine whether IFG is 
more prevalent than IGT in the Korean population as a whole. 
  According to an IDF consensus statement on IGT/IFG in 
2001, the prevalence of IFG tends to plateau in 40 to 50 year 
age group and is more common in men than in women in vir-
tually all age groups [11]. Conversely, the prevalence of IGT is 
higher in women than in men in all age groups, with the ex-
ception of the over 60 age group in Asian populations [11]. 
These findings are consistent with the present findings. Other 
recent epidemiological studies have reported similar sex dif-
ferences in the prevalence of IFG and IGT, with IFG being more 
common in men and IGT more common in women [27,28]. It 
has been hypothesized that the finding of a higher prevalence 
of IGT in women may result from the use of a fixed glucose 
load in the OGTT irrespective of body size, despite the fact 
that women generally have a smaller stature and less muscle 
mass than men [27]. It is unclear whether other factors may 
influence these results, since studies in a number of geographi-
cally and ethnically diverse populations have demonstrated 
sex differences [28]. Further studies will be necessary to estab-
lish whether our results apply to other populations, and to elu-
cidate the mechanisms underlying sex differences in glucose 
metabolism.
  The present study identified significant differences in DM-
associated metabolic risk factors such as BMI, waist circum-
ference, SBP, DBP, TG, TC, and HDL-C between the NGT 
group and the prediabetes and DM groups. Thus, the present 
findings are in accordance with those of previous studies and 
suggest that prediabetes is associated with cardiovascular risk 
factors, such as hypertension and dyslipidemia [7,11,12].
  The present study had several limitations. Previous studies 
from Korea used different standard populations and applied 
different diagnostic criteria for DM and prediabetes. Thus, the 
prevalence of DM and prediabetes identified in the present 
study cannot be compared directly to those reported by previ-
ous studies. Caution should be exercised in interpreting the 
results as an indication of the epidemiology of DM in Korea, 
since the investigation of the Dalseong cohort represents a 
well-controlled epidemiological survey.
  In conclusion, the prevalence of DM in the present rural co-
hort was 12.2% (ASR 6.8%), and that of prediabetes was 22.7% 
(ASR 18.5%). These findings could be used as baseline data for 
a 5-year follow-up study of the prevalence and incidence of DM 
and prediabetes, and of the risk factors associated with the de-
velopment of DM in the Dalseong-gun community. The pres-
ent study has demonstrated the effectiveness of community 
health promotion strategies in facilitating the early detection 
and prevention of DM through a liaison between public and 
private health services. Such strategies are a useful tool in eval-
uating past and current health promotion policies, and in es-
tablishing long-term national health promotion policies. 
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